ID   K420L
AC   CVCL_TZ80
DR   Wikidata; Q54899285
RX   PubMed=17725806;
RX   PubMed=19799608;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
RX   PubMed=17725806; DOI=10.1111/j.1349-7006.2007.00586.x; PMCID=PMC11159108;
RA   Baba T., Hanagiri T., Ichiki Y., Kuroda K., Shigematsu Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Sugio K., Yasumoto K.;
RT   "Lack and restoration of sensitivity of lung cancer cells to cellular
RT   attack with special reference to expression of human leukocyte
RT   antigen class I and/or major histocompatibility complex class I chain
RT   related molecules A/B.";
RL   Cancer Sci. 98:1795-1802(2007).
//
RX   PubMed=19799608; DOI=10.1111/j.1349-7006.2009.01351.x; PMCID=PMC11159900;
RA   Kuroda K., Takenoyama M., Baba T., Shigematsu Y., Shiota H.,
RA   Ichiki Y., Yasuda M., Uramoto H., Hanagiri T., Yasumoto K.;
RT   "Identification of ribosomal protein L19 as a novel tumor antigen
RT   recognized by autologous cytotoxic T lymphocytes in lung
RT   adenocarcinoma.";
RL   Cancer Sci. 101:46-53(2010).
//